These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6862049)

  • 41. Use of H-2:H-7 congenic mice to study H-2-mediated resistance to Friend leukemia virus.
    Wettstein PJ; Blank KJ
    J Immunol; 1982 Jul; 129(1):358-61. PubMed ID: 7086137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in expression of MHC products between several H-2-restricted CTL clones.
    Hauptfeld V; Braciale TJ; Shreffler DC
    J Immunol; 1982 May; 128(5):2026-31. PubMed ID: 6977581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on natural killer (NK) cells. II. Serologic evidence for heterogeneity of murine NK cells.
    Burton RC; Bartlett SP; Kumar V; Winn HJ
    J Immunol; 1981 Nov; 127(5):1864-8. PubMed ID: 6975301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytotoxic T cell response to minor histocompatibility antigens: apparent lack of H-2 restriction in killers stimulated by membrane fragments.
    Pilarski LM; Vergidis D
    J Exp Med; 1982 Jul; 156(1):217-29. PubMed ID: 6177821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
    Yamada J; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacologic effects on mouse isolated atria of immunoglobulins directed against class I histocompatibility antigens.
    Cremaschi GA; Sterin-Borda L; Genaro AM; Borda ES; Braun M
    J Immunol; 1984 Nov; 133(5):2681-5. PubMed ID: 6481168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas.
    Klitzman JM; Brown JP; Hellström KE; Hellström I
    J Immunol; 1980 Jun; 124(6):2552-6. PubMed ID: 6246166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic determination of the immune response in mice to cells of different histological type.
    Lavrovsky VA; Viksler VK; Yurchenko YA; Razvorotnev VA
    Immunology; 1979 Apr; 36(4):835-41. PubMed ID: 108209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-H-2 antibodies induced by syngeneic immunization.
    Iványi P; van Mourik P; Breuning M; Melief CJ
    Immunogenetics; 1980; 10(4):319-32. PubMed ID: 22457924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Target sites for antibodies and cytotoxic T lymphocytes on H-2 molecules.
    Rüsch E; Kuon W; Hämmerling GJ
    Transplant Proc; 1983 Dec; 15(4):2093-6. PubMed ID: 6200977
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantitative differences in the expression of parentally-derived H-2 antigens in F1 hybrid mice affect T-cell responses.
    O'Neill HC; Blanden RV
    J Exp Med; 1979 Mar; 149(3):724-31. PubMed ID: 107262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. III. Periodic production of a cell surface glycoprotein and changes in reactivity with cytotoxic T cells and anti-H-2d sera.
    Celis E; Chang TW; Eisen HN
    J Immunol; 1979 Jun; 122(6):2245-50. PubMed ID: 312862
    [No Abstract]   [Full Text] [Related]  

  • 55. H-2 restriction of adoptive immunotherapy of advanced tumors.
    Greenberg PD; Cheever MA; Fefer A
    J Immunol; 1981 Jun; 126(6):2100-3. PubMed ID: 6453154
    [No Abstract]   [Full Text] [Related]  

  • 56. Production of antibodies against ML antigen in the xenogeneic host.
    Radzikowski C; Zak-Nejmark T; Wysocka M; Steuden J
    Arch Immunol Ther Exp (Warsz); 1977; 25(4):507-13. PubMed ID: 931552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Confirmation of genetic control of response to trinitrophenyl-modified H-2 antigens by the use of anti-H-2 and anti-Ia antibodies.
    Schmitt-Verhulst AM; Sachs DH; Shearer GM
    J Exp Med; 1976 Jan; 143(1):211-7. PubMed ID: 1244419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of immune responses in mice after transfusions from single or multiple H-2 donors.
    Joseph S; Singal DP; Ludwin D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1168. PubMed ID: 2705218
    [No Abstract]   [Full Text] [Related]  

  • 59. Genetic control of the production of anti-thyroid hormone antibodies in mice immunized with human thyroglobulin.
    Sakata S; Okuda K; Aihara Y; Tanaka Y; Nakamura S; Komaki T; Tarutani O; Miura K
    Immunol Invest; 1986 Aug; 15(5):481-92. PubMed ID: 3096882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specificities of NZB anti-H-2d CML reactions: role of Qa-1 and retroviral gp70 antigens.
    Theofilopoulos AN; Shawler DL; Balderas RS; Elder JH; Katz DH; Dixon FJ
    J Immunol; 1981 Mar; 126(3):1154-9. PubMed ID: 6161961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.